Articles From: VIVUS Reports Third Quarter 2014 Financial Results to Amgen Announces Top-Line Secondary Endpoint Results Of Phase 3 Trebananib TRINOVA-1 Trial In Patients With Recurrent Ovarian Cancer


http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G025569-001&sourceType=1 http://www.marketwire.com/library/MwGo/2014/11/5/11G025569/vivu0508-1319848479825.jpg MOUNTAIN VIEW, CA--(Marketwired - November 05, 2014) - VIVUS, Inc. (NASDAQ: VVUS), a biopharmaceutical company commercializing Qsymia ® (phentermine and topiramate extended-release) capsules CIV for the treatment of obesity, today reported its financial results for the third quarter ended September 30, 2014 and provided a business update.
Sign-up for VIVUS Reports Third Quarter 2014 Financial Results investment picks
-- Company Signs Definitive Agreement to Acquire Telesphere -- --
Sign-up for Vonage Holdings Corp. Reports Third Quarter 2014 Results investment picks
NEW YORK , Nov.
Sign-up for Voya Financial Announces Third Quarter 2014 Results investment picks
Waddell & Reed Financial, Inc. (NYSE: WDR) Chief Financial Officer Brent K.
Sign-up for Waddell & Reed Presenting at Bank of America/Merrill Lynch Conference investment picks
Walgreens (NYSE: WAG) (Nasdaq: WAG) had October sales of $6.80 billion, an increase of 6.9 percent from $6.36 billion for the same month in fiscal 2014.
Sign-up for Walgreens October Sales Increase 6.9 Percent investment picks
Don Chappel, a senior executive of Williams (NYSE: WMB), Williams Partners L.P. (NYSE: WPZ) and Access Midstream Partners, L.P. (NYSE: ACMP), is scheduled to present at the Jefferies 2014 Global Energy Conference Wednesday, Nov.
Sign-up for Williams, Williams Partners L.P. and Access Midstream Partners, L.P. to Present at Jefferies 2014 Global Energy Conference investment picks
Wizard World, Inc .
Sign-up for Wizard World Reports Continued Growth in Third Quarter 2014: 67% Increase from Q3 2013 investment picks
2014/11/5
Record quarterly Revenue of $88.6 million, up 66% over third quarter 2013.
Sign-up for Zillow, Inc. Reports Record Third Quarter 2014 Results investment picks
2014/11/5
By Rex Crum, MarketWatch SAN FRANCISCO (MarketWatch)--An upbeat earnings reports wasn't enough to bail out Zulily Inc. on Wednesday as the online flash-sale retailer's share plunged more than 21% after a weaker-than-expected sales forecast.
Sign-up for Zulily's stock falls on sales forecast investment picks
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1156549&ProfileId=051205&sourceType=1 LYNNWOOD, WA --
Sign-up for Zumiez Inc. Reports October 2014 Sales Results investment picks
PHILADELPHIA , Nov.
Sign-up for "The Power of Red" Continues as Republic Bank Strengthens New Jersey Lending Team investment picks
BATON ROUGE, La., Nov.
Sign-up for 2014 HomeCare Elite Recognizes Top Amedisys Care Teams Nationwide investment picks
Zurich Insurance Group (Zurich) has gone live with its new global corporate website ( www.zurich.com ) that was built with help from Accenture (NYSE:ACN). Zurich’s website was revamped to enhance digital interactions with consumers and better support its global digital marketing strategy.
Sign-up for Accenture Helps Zurich Insurance Group Revamp Global Corporate Website to Support Digital Marketing Strategy investment picks
The Total Cost of Ownership for HR Is a Big Number that is Rarely Understood and Frequently Underestimated ROSELAND, N.J. , Nov.
Sign-up for ADP Research Institute® Uncovers a Gap in Understanding the 'All-In' Cost of Managing a Midsized Workforce investment picks
2014/11/4
Integration of RiseSmart's® Next-Generation Outplacement Solution Helps Employees in Transition Find the Right Jobs, Update Their Application Materials and Seek Guidance on Their Job Search ROSELAND, N.J. , Nov.
Sign-up for ADP Supports Applicants Reentering the Workforce with New Additions to the ADP SmartCompliance® Unemployment Claims Module investment picks
Immunotherapy Candidate for Pediatric Osteosarcoma, ADXS-cHER2, Delays Metastatic Disease and Prolongs Overall Survival in Canine Osteosarcoma PRINCETON, N.J., Nov.
Sign-up for Advaxis to Present Survival Data of Lm-LLO Cancer Immunotherapies in Recurrent Cervical Cancer and Canine Osteosarcoma at the Society for Immunotherapy of Cancer 29th Annual Meeting investment picks
http://media.marketwire.com/attachments/201405/75182_ADVENT.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1155973&ProfileId=051205&sourceType=1 SAN FRANCISCO, CA and LONDON, UNITED KINGDOM --
Sign-up for Advent Wins Best Technology Provider at Investment Week Fund Services Awards 2014 investment picks
Aetna (NYSE: AET ) announced today that Shawn M.
Sign-up for Aetna Announces Appearance at Credit Suisse 2014 Healthcare Conference investment picks
FARMINGTON HILLS, Mich.
Sign-up for Agree Realty Announces $15.2 Million Burger King Sale Leaseback Transaction investment picks
LEXINGTON, Ky.
Sign-up for Alberta Health Services selects Lexmark for managed print services investment picks
2014/11/4
Alcoa (NYSE:AA) executives today said that they continue to aggressively reposition the Company and that they are on track to successfully deliver against business targets introduced last year.
Sign-up for Alcoa Successfully Tracking Against Business Targets, Portfolio Transformation Advancing investment picks
BOTHELL, Wash., Nov.
Sign-up for Alder BioPharmaceuticals to Present at Credit Suisse 2014 Healthcare Conference investment picks
Allergan, Inc. (NYSE: AGN) (“Allergan” or the “Company”) today commented on the ruling in the United States District Court for the Central District of California in the Company’s federal securities litigation against Valeant Pharmaceuticals International, Inc. (“Valeant”), Pershing Square Capital Management, L.P. (“Pershing Square”) and its principal, William A.
Sign-up for Allergan Comments on California Federal Court Ruling in Insider Trading Lawsuit against Valeant & Pershing Square investment picks
(NASDAQ:AMZN)—Amazon today introduced Prime Photos, the newest benefit for Prime members, which provides free unlimited photo storage in Amazon Cloud Drive.
Sign-up for Amazon Prime Members Can Now Enjoy Free Unlimited Photo Storage with Prime Photos investment picks
Study Failed to Meet Secondary Endpoint of Overall Survival THOUSAND OAKS, Calif.
Sign-up for Amgen Announces Top-Line Secondary Endpoint Results Of Phase 3 Trebananib TRINOVA-1 Trial In Patients With Recurrent Ovarian Cancer investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: VIVUS Reports Third Quarter 2014 Financial Results to Amgen Announces Top-Line Secondary Endpoint Results Of Phase 3 Trebananib TRINOVA-1 Trial In Patients With Recurrent Ovarian Cancer
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent